Glitazones, PPAR-γ and Neuroprotection
Autor: | P. Prabitha, B. R. Prashantha Kumar, Victoria Jeyarani, Ashwini Prem Kumar, S P Dhanabal, Antony Justin |
---|---|
Rok vydání: | 2021 |
Předmět: |
Pharmacology
chemistry.chemical_classification In silico Neurodegeneration Peroxisome proliferator-activated receptor General Medicine Biology medicine.disease Neuroprotection Cell biology PPAR gamma Pathogenesis Neuroprotective Agents Mitochondrial biogenesis chemistry Nuclear receptor Downregulation and upregulation Drug Discovery medicine Animals Humans Thiazolidinediones |
Zdroj: | Mini-Reviews in Medicinal Chemistry. 21 |
ISSN: | 1389-5575 |
DOI: | 10.2174/1389557521666210304112403 |
Popis: | The transcriptional factor PPAR-γ belongs to the nuclear receptor family, which has become a potential therapeutic target for several neurodegenerative diseases and metabolic disorders. Interestingly, PPAR-γ has been reported to have beneficial effects in various chronic neurological conditions via upregulation of its transcriptional co-activator PGC-1α and followed by regulation of multiple molecular events. Although several factors contribute to the progression of neurodegeneration, the dysfunction of PGC-1α expression is primarily interlinked with the pathogenesis of major neurodegenerative diseases. This review gives an insight that ligand-dependent activation of PPAR-γ by glitazones could initiate the structural conformational changes of the secondary proteins, thus recruiting the PGC-1α to form a regulatory stable complex which hampers the various molecular pathways contributing to neurodegeneration. The promising outcomes of the preliminary in silico studies included in this review support that PPAR-γ dependent activation of central PGC-1α signaling by novel glitazones is an encouraging strategy to enhance the oxy-radicals detoxifying system, anti-inflammatory responses, and mitochondrial biogenesis required for neuroprotection in various neurodegenerative conditions. |
Databáze: | OpenAIRE |
Externí odkaz: |